Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cutting-edge drug resistance analysis of major cancers at single-cell level

Cancer Treatment and Research Communications(2025)10.1016/j.ctarc.2025.101043Source: DataRank Database

Cutting-edge drug resistance analysis of major cancers at single-cell level is a research paper published in Cancer Treatment and Research Communications (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: goldIDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Zhiyuan Cao,Wenxin Long,Luca Pinello ORCID,Tianyu Liu ORCID

Live enrichment

PubMed:19022398

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.ctarc.2025.101043

publisherhttps://api.elsevier.com/content/article/PII:S2468294225001790?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468294225001790?httpAccept=text/plain

repositoryhttps://doaj.org/article/906b44d992484e41aed8181b683ee391